Newton BioCapital

VC · Brussels (Belgium)

VC

Seed

Series A

Hardware

Healthcare

Sign up free to access full profile and submit your pitch.

About

Newton Biocapital is a venture capital firm specializing in start-up, early-stage and late-stage investments. The fund seeks to invest in pharmaceutical, biotech and life science projects with a focus on prevention and treatment of chronic diseases. It prefers to invest in the core of Europe and Japan. Newton Biocapital was founded in 2017 and is based in Brussels, Belgium and additional office in Tokyo, Japan.

Investment Criteria

Other investors that have backed the same portfolio companies as Newton BioCapital. Expand any entry to see the shared portfolio companies.

• Sambrinvest S.A.

  6 shared

  Shared portfolio companies

  • AbolerIS Pharma
  • AdipoPharma SAS
  • Cellaïon SA/NV
  • EPICS Therapeutics SA
  • NeuVasQ Biotechnologies
  • Santero Therapeutics SRL
• Investsud sa

  4 shared

  Shared portfolio companies

  • AdipoPharma SAS
  • DeuterOncology NV
  • NeuVasQ Biotechnologies
  • Synergia Medical SA
• Mitsubishi UFJ Capital

  3 shared

  Shared portfolio companies

  • J-Pharma Co., Ltd.
  • Perseus Proteomics Inc.
  • Tensegrity Pharma, Inc
• PMV

  3 shared

  Shared portfolio companies

  • Augustine Therapeutics N.V.
  • Sequana Medical AG
  • Sequana Medical NV
• BioMed Partners

  2 shared

  Shared portfolio companies

  • Sequana Medical AG
  • Sequana Medical NV
• DBJ Capital

  2 shared

  Shared portfolio companies

  • Perseus Proteomics Inc.
  • PRISM BioLab Co.,LTD
• Fund+

  2 shared

  Shared portfolio companies

  • Cellaïon SA/NV
  • EPICS Therapeutics SA
• Mizuho Capital Co., Ltd.

  2 shared

  Shared portfolio companies

  • J-Pharma Co., Ltd.
  • Perseus Proteomics Inc.
• Nippon Venture Capital

  2 shared

  Shared portfolio companies

  • J-Pharma Co., Ltd.
  • Perseus Proteomics Inc.
• QB Capital, LLC

  2 shared

  Shared portfolio companies

  • EditForce Inc.
  • J-Pharma Co., Ltd.